Natural health product · NPN 80069647
Probaclac E
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed May 24, 2016; licence last revised December 22, 2020.
- Natural Product Number (NPN)
- 80069647
- Licence holder
- Les laboratoires Nicar inc.Blainville, QC, Canada
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- CompendialThe company attested that the product meets a Health Canada monograph.
- First licensed
- May 24, 2016
- Licence last revised
- December 22, 2020
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Lactobacillus casei | 300 % | Lactobacillus casei A179 |
| Lactobacillus casei | 863 billion cfu | Lactobacillus casei A179 |
| Lactobacillus casei | 300 % | Whole cell |
| Lactobacillus casei | 863 billion cfu | Whole cell |
| Lactobacillus paracasei | 300 % | Lactobacillus paracasei A234 |
| Lactobacillus paracasei | 1,463 billion cfu | Lactobacillus paracasei A234 |
| Lactobacillus paracasei | 300 % | Whole cell |
| Lactobacillus paracasei | 1,463 billion cfu | Whole cell |
| Bifidobacterium longum subsp. longum | 300 % | Bifidobacterium longum subsp. longum A027 |
| Bifidobacterium longum subsp. longum | 113 billion cfu | Bifidobacterium longum subsp. longum A027 |
| Bifidobacterium longum subsp. longum | 300 % | Whole cell |
| Bifidobacterium longum subsp. longum | 113 billion cfu | Whole cell |
| Lactobacillus rhamnosus | 300 % | A-119 |
| Lactobacillus rhamnosus | 1,463 billion cfu | A-119 |
| Lactobacillus rhamnosus | 300 % | Lactobacillus rhamnosus - Whole cell |
| Lactobacillus rhamnosus | 1,463 billion cfu | Lactobacillus rhamnosus - Whole cell |
| Lactobacillus acidophilus | 300 % | Lactobacillus acidophilus - Whole cell |
| Lactobacillus acidophilus | 113 billion cfu | Lactobacillus acidophilus - Whole cell |
| Lactobacillus acidophilus | 300 % | A-118 |
| Lactobacillus acidophilus | 113 billion cfu | A-118 |
| Bifidobacterium breve | 300 % | Whole cell |
| Bifidobacterium breve | 338 billion cfu | Whole cell |
| Bifidobacterium breve | 300 % | Bifidobacterium breve A055 |
| Bifidobacterium breve | 338 billion cfu | Bifidobacterium breve A055 |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- N/A
Non-medicinal ingredients
Sucrose; Ascorbic acid; Microcrystalline cellulose; Sorbitol; Maltodextrin; Anthocyanines; Magnesium Stearate; Grape flavour; Beetroot red; Inulin; Corn Starch; Citric acid; Silicon dioxide